[go: up one dir, main page]

PT2830658T - Formulações de agente de ligação igg4 estável - Google Patents

Formulações de agente de ligação igg4 estável

Info

Publication number
PT2830658T
PT2830658T PT13714505T PT13714505T PT2830658T PT 2830658 T PT2830658 T PT 2830658T PT 13714505 T PT13714505 T PT 13714505T PT 13714505 T PT13714505 T PT 13714505T PT 2830658 T PT2830658 T PT 2830658T
Authority
PT
Portugal
Prior art keywords
binding agent
agent formulations
igg4 binding
stable igg4
stable
Prior art date
Application number
PT13714505T
Other languages
English (en)
Inventor
Usener Dirk
Youssef Ahmed
Hagendorf Annika
Kirsch Martina
Ruggeberg Sabrina
Schnieders Julia
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of PT2830658T publication Critical patent/PT2830658T/pt

Links

PT13714505T 2012-03-26 2013-03-26 Formulações de agente de ligação igg4 estável PT2830658T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261615539P 2012-03-26 2012-03-26
FR1351013 2013-02-06

Publications (1)

Publication Number Publication Date
PT2830658T true PT2830658T (pt) 2018-12-28

Family

ID=54834982

Family Applications (1)

Application Number Title Priority Date Filing Date
PT13714505T PT2830658T (pt) 2012-03-26 2013-03-26 Formulações de agente de ligação igg4 estável

Country Status (4)

Country Link
JP (1) JP6820823B2 (pt)
ES (1) ES2702246T3 (pt)
HK (1) HK1204990A1 (pt)
PT (1) PT2830658T (pt)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040033228A1 (en) * 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
CN101426817B (zh) * 2006-04-21 2013-07-10 诺华有限公司 拮抗性抗-cd40抗体药物组合物
CA2661782C (en) * 2006-08-28 2019-04-16 La Jolla Institute For Allergy And Immunology Antagonistic human light-specific human monoclonal antibodies
WO2008121615A2 (en) * 2007-03-30 2008-10-09 Medimmune, Inc. Antibody formulation
FI20075278A0 (fi) * 2007-04-20 2007-04-20 Biotie Therapies Corp Uudet täysin ihmisperäiset anti-VAP-1 monoklonaaliset vasta-aineet
HUE037489T2 (hu) * 2007-08-29 2018-08-28 Sanofi Sa Humanizált anti-CXCR5 antitestek, azok származékai és alkalmazásuk
FR2942799B1 (fr) * 2009-03-06 2011-02-25 Lfb Biotechnologies Anticorps monoclonal anti-rhesus d
JO3417B1 (ar) * 2010-01-08 2019-10-20 Regeneron Pharma الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
US20130136733A1 (en) * 2010-05-28 2013-05-30 Novo Nordisk A/S Stable Multi-Dose Compositions Comprising an Antibody and a Preservative

Also Published As

Publication number Publication date
HK1204990A1 (en) 2015-12-11
JP2018048174A (ja) 2018-03-29
JP6820823B2 (ja) 2021-01-27
ES2702246T3 (es) 2019-02-28

Similar Documents

Publication Publication Date Title
IL286348A (en) Pharmaceutical preparations that include allopregnanolone
PL2830658T3 (pl) Stabilne formulacje środków wiążących lgG4
SG11201404577XA (en) Bactericidal agent composition
ZA201502013B (en) Nicotine composition
ZA201500212B (en) Progesterone formulations
IL235322A0 (en) Pesticides
IL235585B (en) Substances that bind to ha, preparations containing them and their uses
GB2502339B (en) Solid cosmetic composition
PL2582761T3 (pl) Wodne kompozycje środków wiążących
GB201200707D0 (en) Composition
IL233824A (en) Compounds 1h - Indazole - 3 - Carboxamide, preparations containing them and their use
SG11201406278PA (en) Pesticidal composition
AP3681A (en) Modified release formulations for oprozomib
PL2830589T3 (pl) Preparat nikotynowy
EP2878295A4 (en) COMPOSITION
SG11201500544SA (en) Composition for agent for external use
ZA201503755B (en) Herbicide composition
GB2507522B (en) Solid cosmetic composition
EP2856873A4 (en) HERBICIDE COMPOSITION
GB201210530D0 (en) Extended release formulations
GB201105162D0 (en) Improved deodorant formulations
EP2910537A4 (en) AGENT COMPOSITION GENERATING GAS
PT2830658T (pt) Formulações de agente de ligação igg4 estável
GB201206178D0 (en) Formulations
GB201214449D0 (en) Fragrancing composition